Forgot your password ?

 login: 

  Why you need to be registered

 password: 

 Register 

Current issueArchivesubscribeInstructions to Authors

search by
Google





subscribe on the news  

 

Pay Color Illustration
 


Medline

PubMed, a service of the National Library of Medicine

World Oncology Network

R.E.Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology



Vol. 26, No. 1, 2004 (March)

Content

ENHANCEMENT OF ANTITUMOR RESPONSE TO SARCOMA 45 IN RATS BY COMBINATION OF WHOLE-BODY HYPERTHERMIA AND INTERLEUKIN-2

 

Michael P. Potapnev1,*, Yuri P. Istomin2, Reiman S. Ismail-zade1, Edvard A. Zhavrid2

1Research Department, Belarussian Research Center for Pediatric Oncology & Hematology, P.O. Lesnoy, Minsk BE-223052, Belarus
2N.N. Alexandrov Research Institute of Oncology & Medical Radiology, P.O. Lesnoy-2, 223040 Minsk, Belarus

Abstract. Aim: To evaluate the summarized effect of hyperthermia and interleukin-2 (IL-2) administration on antitumor defense in tumor-bearing rats. Methods: Nonbred rats after subcutaneous inoculation of sarcoma 45 cells were treated with whole-body hyperthermia (WBH, +42.5 оС, 60 min) and interleukin-2 (IL-2, 10 000 U/kg of body weight). Parameters of tumor growth and survival of animals were monitored till day 33 after tumor cell inoculation. Results: Combined application of WBH and IL-2 at 5th day after tumor cell transplantation resulted in a delay of tumor growth and improvement of survival parameters in comparison with control group or animals that received separate treatment. Therapeutic efficacy of WBH combined with IL-2 was analogous to a single-dose chemotherapy with cyclophosphamide. Conclusion: Combined application of WBH and IL-2 is the useful approach for cancer immunotherapy.

Key Words: hyperthermia, interleukin-2, sarcoma 45, rats.

Language:  English

[full text]




Copyright (c) MORION 1999-2008

Current issue | Archive | subscribe | Instructions to Authors | E-Mail to webmaster